Skip to main content
Top
Published in: Advances in Gerontology 3/2023

07-03-2024 | Alzheimer's Disease | REVIEWS

Mechanisms of Neurocognitive Adaptation during Aging Process

Author: M. A. Cherdak

Published in: Advances in Gerontology | Issue 3/2023

Login to get access

Abstract

Human aging is associated with an increased risk of various geriatric syndromes, cognitive impairment being among the most frequent. The most prominent form of the cognitive impairment—dementia—has become one of the major course of dependency in older and oldest old patients. Nevertheless, it has been shown that despite the fact that various parts of the brain change structurally over time due to natural aging or diseases, it does not necessarily manifest into clinical symptoms for some older people. Therefore, there is a dissociation of the severity of morphological and functional brain changes. The review presents current data on adaptive mechanisms that ensure the preservation of neurocognitive activity during aging process. In addition to the concept of brain and cognitive reserves, it discusses different mechanisms of neurocognitive maintenance and compensation both in the norm and in the development of Alzheimer’s disease. The possibility of their clinical and instrumental assessment and practical significance are discussed.
Literature
2.
go back to reference Bogolepova, A.N., Vasenina, E.E., Gomzyakova, N.A., Gusev, E.I., Dudchenko, N.G., Emelin, A.Yu., Zalutskaya, N.M., Isaev, R.I., Kotovskaya, Yu.V., Levin, O.S., Litvinenko, I.V., Lobzin, V.Yu., Martynov, M.Yu., Mkhitaryan, E.A., Neznanov, N.G., Palchikova, E.I., Tkacheva, O.N., Cherdak, M.A., Chimagomedova, A.Sh., and Yakhno, N.N., Clinical guidelines for cognitive disorders in elderly and older patients, Zh. Nevr. Psikhiatr. im. S.S. Korsakova, 2021, vol. 121, no. 10–3, pp. 6–137. https://doi.org/10.17116/jnevro20211211036 Bogolepova, A.N., Vasenina, E.E., Gomzyakova, N.A., Gusev, E.I., Dudchenko, N.G., Emelin, A.Yu., Zalutskaya, N.M., Isaev, R.I., Kotovskaya, Yu.V., Levin, O.S., Litvinenko, I.V., Lobzin, V.Yu., Martynov, M.Yu., Mkhitaryan, E.A., Neznanov, N.G., Palchikova, E.I., Tkacheva, O.N., Cherdak, M.A., Chimagomedova, A.Sh., and Yakhno, N.N., Clinical guidelines for cognitive disorders in elderly and older patients, Zh. Nevr. Psikhiatr. im. S.S. Korsakova, 2021, vol. 121, no. 10–3, pp. 6–137. https://​doi.​org/​10.​17116/​jnevro2021121103​6
5.
go back to reference Satz, P., Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory, Neuropsychology, 1993, vol. 7, no. 3, pp. 273–295. Satz, P., Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory, Neuropsychology, 1993, vol. 7, no. 3, pp. 273–295.
16.
go back to reference Solé-Padullés, C., Bartrés-Faz, D., Junqué, C., Vendrell, P., Rami, L., Clemente, I.C., Bosch, B., Villar, A., Bargalló, N., Jurado, M.A., Barrios, M., and Molinuevo, J.L., Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer’s disease, Neurobiol. Aging, 2009, vol. 30, no. 7, pp. 1114–1124. https://doi.org/10.1016/j.neurobiolaging.2007.10.008CrossRefPubMed Solé-Padullés, C., Bartrés-Faz, D., Junqué, C., Vendrell, P., Rami, L., Clemente, I.C., Bosch, B., Villar, A., Bargalló, N., Jurado, M.A., Barrios, M., and Molinuevo, J.L., Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer’s disease, Neurobiol. Aging, 2009, vol. 30, no. 7, pp. 1114–1124. https://​doi.​org/​10.​1016/​j.​neurobiolaging.​2007.​10.​008CrossRefPubMed
20.
go back to reference Petersen, R.C., Lopez, O., Armstrong, M.J., Getchius, T.S.D., Ganguli, M., Gloss, D., Gronseth, G.S., Marson, D., Pringsheim, T., Day, G.S., Sager, M., Stevens, J., and Rae-Grant, A., Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation subcommittee of the American Academy of Neurology, Neurology, 2018, vol. 90, no. 3, pp. 126–135. https://doi.org/10.1212/WNL.0000000000004826CrossRefPubMedPubMedCentral Petersen, R.C., Lopez, O., Armstrong, M.J., Getchius, T.S.D., Ganguli, M., Gloss, D., Gronseth, G.S., Marson, D., Pringsheim, T., Day, G.S., Sager, M., Stevens, J., and Rae-Grant, A., Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation subcommittee of the American Academy of Neurology, Neurology, 2018, vol. 90, no. 3, pp. 126–135. https://​doi.​org/​10.​1212/​WNL.​0000000000004826​CrossRefPubMedPubMedCentral
21.
24.
go back to reference Collaboratory on Research Definitions for Cognitive Reserve and Resilience. https://reserveandresilience.com/. Cited on June 24, 2023. Collaboratory on Research Definitions for Cognitive Reserve and Resilience. https://​reserveandresili​ence.​com/​.​ Cited on June 24, 2023.
26.
go back to reference Rami, L., Valls-Pedret, C., Bartrés-Faz, D., Caprile, C., Sole-Padulles, C., Castellvi, M., Olives, J., Bosch, B., and Molinuevo, J.L., Cognitive reserve questionnaire. Scores obtained in a healthy elderly population and in one with Alzheimer’s disease, Rev. Neurol., 2011, vol. 52, no. 4, pp. 195–201. https://doi.org/10.33588/rn.5204.2010478CrossRefPubMed Rami, L., Valls-Pedret, C., Bartrés-Faz, D., Caprile, C., Sole-Padulles, C., Castellvi, M., Olives, J., Bosch, B., and Molinuevo, J.L., Cognitive reserve questionnaire. Scores obtained in a healthy elderly population and in one with Alzheimer’s disease, Rev. Neurol., 2011, vol. 52, no. 4, pp. 195–201. https://​doi.​org/​10.​33588/​rn.​5204.​2010478CrossRefPubMed
29.
go back to reference Amoretti, S., Cabrera, B., Torrent, C., Bonnín, C.D.M., Mezquida, G., Garriga, M., Jimenéz, E., Martínez-Arán, A., Solé, B., Reinares, M., Varo, C., Penades, R., Grande, I., Salagre, E., Parellada, E., Bioque, M., Garcia-Rizo, C., Meseguer, A., Anmella, G., Rosa, A.R., Contreras, F., Safont, G., Vieta, E., and Bernardo, M., Cognitive Reserve Assessment Scale in Health (CRASH): Its validity and reliability, J. Clin. Med., 2019, vol. 8, no. 5, p. 586. https://doi.org/10.3390/jcm8050586CrossRefPubMedPubMedCentral Amoretti, S., Cabrera, B., Torrent, C., Bonnín, C.D.M., Mezquida, G., Garriga, M., Jimenéz, E., Martínez-Arán, A., Solé, B., Reinares, M., Varo, C., Penades, R., Grande, I., Salagre, E., Parellada, E., Bioque, M., Garcia-Rizo, C., Meseguer, A., Anmella, G., Rosa, A.R., Contreras, F., Safont, G., Vieta, E., and Bernardo, M., Cognitive Reserve Assessment Scale in Health (CRASH): Its validity and reliability, J. Clin. Med., 2019, vol. 8, no. 5, p. 586. https://​doi.​org/​10.​3390/​jcm8050586CrossRefPubMedPubMedCentral
30.
go back to reference Jack, C.R., Jr., Bennett, D.A., Blennow, K., Carrillo, M.C., Dunn, B., Haeberlein, S.B., Holtzman, D.M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J.L., Montine, T., Phelps, C., Rankin, K.P., Rowe, C.C., Scheltens, P., Siemers, E., Snyder, H.M., and Sperling, R., Contributors. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease, Alzheimers Dement., 2018, vol. 14, no. 4, pp. 535–562. https://doi.org/10.1016/j.jalz.2018.02.018CrossRefPubMed Jack, C.R., Jr., Bennett, D.A., Blennow, K., Carrillo, M.C., Dunn, B., Haeberlein, S.B., Holtzman, D.M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J.L., Montine, T., Phelps, C., Rankin, K.P., Rowe, C.C., Scheltens, P., Siemers, E., Snyder, H.M., and Sperling, R., Contributors. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease, Alzheimers Dement., 2018, vol. 14, no. 4, pp. 535–562. https://​doi.​org/​10.​1016/​j.​jalz.​2018.​02.​018CrossRefPubMed
Metadata
Title
Mechanisms of Neurocognitive Adaptation during Aging Process
Author
M. A. Cherdak
Publication date
07-03-2024
Publisher
Pleiades Publishing
Published in
Advances in Gerontology / Issue 3/2023
Print ISSN: 2079-0570
Electronic ISSN: 2079-0589
DOI
https://doi.org/10.1134/S2079057024600204

Other articles of this Issue 3/2023

Advances in Gerontology 3/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine